Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01011985 · ClinicalTrials.gov registry record
A Study Evaluating the Association of Inflammation With Hemodialysis Access Type
A clinical trial of Inflammation and End Stage Renal Disease, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- 64
- Enrollment target
- 1
- Study location
NCT01011985: Completed study of Inflammation and End Stage Renal Disease, sponsored by Montefiore Medical Center.
NCT01011985 is a study of Inflammation and End Stage Renal Disease that has completed, run by Montefiore Medical Center. The registered enrollment target is 64 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01011985, a study of Inflammation and End Stage Renal Disease, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if the type of hemodialysis vascular access correlates with markers of inflammation, namely C-reactive protein and interleukin-6, and with both access and patient survival in the end stage renal disease population.
Conditions Studied
Study Locations (1)
New York
- Montefiore Medical Center and Jack D Weiler Hospital - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2006-08 |
| Est. Completion | 2008-06 |
What the finished NCT01011985 record still lists
NCT01011985 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Inflammation appearing as the primary indexed condition, and to 0 interventions.
NCT01011985 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01011985 about?
NCT01011985 is a clinical study titled "A Study Evaluating the Association of Inflammation With Hemodialysis Access Type". To determine if the type of hemodialysis vascular access correlates with markers of inflammation, namely C-reactive protein and interleukin-6, and with both access and patient survival in the end stage renal disease population.
What is the current status of trial NCT01011985?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2006-08. Estimated completion is 2008-06.
What conditions does trial NCT01011985 study?
This clinical trial studies the following conditions: Inflammation, End Stage Renal Disease.
Who is sponsoring clinical trial NCT01011985?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01011985 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01011985's enrollment target sits among peer trials
64 66th of 132 higher than 66 of 132 other Inflammation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Reducing Frailty for Older Cancer Survivors Using Supplements II
RECRUITING · Phase 2
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia